Risk of major adverse cardiovascular events in CYP2C19LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta‐analysis.
Saved in:
| Title: | Risk of major adverse cardiovascular events in CYP2C19LoF genotype guided clopidogrel against alternative antiplatelets for CAD patients undergoing PCI: Meta‐analysis. |
|---|---|
| Authors: | Biswas, Mohitosh1,2,3 (AUTHOR), Murad, Murshadul Alam1 (AUTHOR), Ershadian, Maliheh2,3 (AUTHOR), Kali, Most Sumaiya Khatun4 (AUTHOR), Sukasem, Chonlaphat2,3,5,6 (AUTHOR) chonlaphat.suk@mahidol.ac.th |
| Source: | CTS: Clinical & Translational Science. Feb2025, Vol. 18 Issue 2, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
